Xiaqing Ma

Xiaqing Ma

Auto-generated profile, based on publicly available information

Xiaqing Ma

Department of Anesthesiology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2022 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
TCTong Cheng
Tong Cheng
ZXZhongling Xu
Zhongling Xu
XMXiaqing Ma
Xiaqing Ma
Neuropathic pain, whose symptoms are characterized by spontaneous and irritation-induced painful sensations, is a condition that poses a global burden. Numerous neurotransmitters and other chemicals play a role in the emergence and maintenance of neuropathic pain, which is strongly correlated with common clinical challenges, such as chronic pain and depression. However, the mechanism underlying its occurrence and development has not yet been fully elucidated, thus rendering the use of traditional painkillers, such as non-steroidal anti-inflammatory medications and opioids, relatively ineffective in its treatment. Astrocytes, which are abundant and occupy the largest volume in the central nervous system, contribute to physiological and pathological situations. In recent years, an increasing number of researchers have claimed that astrocytes contribute indispensably to the occurrence and progression of neuropathic pain. The activation of reactive astrocytes involves a variety of signal transduction mechanisms and molecules. Signal molecules in cells, including intracellular kinases, channels, receptors, and transcription factors, tend to play a role in regulating post-injury pain once they exhibit pathological changes. In addition, astrocytes regulate neuropathic pain by releasing a series of mediators of different molecular weights, actively participating in the regulation of neurons and synapses, which are associated with the onset and general maintenance of neuropathic pain. This review summarizes the progress made in elucidating the mechanism underlying the involvement of astrocytes in neuropathic pain regulation.

1 March 2021 in Pharmacological Research
Verified
Journal Article
Closed access
HWHaiyan Wang
Haiyan Wang
MHMin Huang
Min Huang
WWWenying Wang
Wenying Wang
YZYu Zhang
Yu Zhang
XMXiaqing Ma
Xiaqing Ma
TXTao Xu
Tao Xu

15 July 2022 in Frontiers in Pain Research
Verified
Journal Article
Open access
JZJiejie Zhuang
Jiejie Zhuang
HMHoulian Mei
Houlian Mei
FFFang Fang
Fang Fang
XMXiaqing Ma
Xiaqing Ma
Chronic musculoskeletal pain (CMP) is the most common type of chronic pain, defined as persistent or recurrent pain condition deriving from musculoskeletal structures such as muscles, joints or bones that lasts for more than 3 months. CMP is multifactorial and severely affects people's quality of life. CMP may be influenced by a number of factors, including contextual factors, the presence of comorbidities, arthritis coping efficacy and access to CMP care. To deepen the comprehensive understanding of CMP, this narrative review provides the latest literature on disease classification, clinical diagnosis, treatment and basic research. In terms of the classification of the disease, here we introduce the 11th edition of the International Classification of Diseases (IDC-11), in which CMP is divided into chronic primary musculoskeletal pain and chronic secondary musculoskeletal pain. In the clinical diagnosis section, the progress of central sensitization in the diagnosis of CMP will also be summarized. In addition, we summarize some recent advances in clinical treatment and basic research.

1 July 2024 in Fundamental Research
Verified
Journal Article
Open access
XMXiaqing Ma
Xiaqing Ma
QQQi Qi
Qi Qi
WWWenying Wang
Wenying Wang
MHMin Huang
Min Huang
HWHaiyan Wang
Haiyan Wang
TXTao Xu
Tao Xu
The activation of spinal astrocytes accounts for opioid-induced hyperalgesia (OIH), but the underlying mechanisms remain elusive. The presence of astrocyte-neuron lactate shuttle (ANLS) makes astrocytes necessary for some neural function and communication. The aim of this study was to explore the role of ANLS in the occurrence and maintenance of OIH. After 7 days consecutive morphine injection, a mice OIH model was established and astrocytic pyruvate dehydrogenase kinase 4 (PDK4), phosphorylated pyruvate dehydrogenase (p-PDH) and accumulation of L-lactate was elevated in the spinal dorsal horn. Intrathecally administration of inhibitors of PDK, lactate dehydrogenase 5 and monocarboxylate transporters to decrease the supply of L-lactate on neurons was observed to attenuate hypersensitivity behaviors induced by repeated morphine administration and downregulate the expression of markers of central sensitization in the spinal dorsal horns. The astrocyte line and the neuronal line were co-cultured to investigate the mechanisms in vitro. In this study, we demonstrated that morphine-induced hyperalgesia was sustained by lactate overload consequent upon aberrant function of spinal ANLS. In this process, PDK-p-PDH-lactate axis serves a pivotal role, which might therefore be a new target to improve long-term opioid treatment strategy in clinical practice.

8 June 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
MHMin Huang
Min Huang
LLLimin Luo
Limin Luo
WWWenying Wang
Wenying Wang
HXHao Xu
Hao Xu
MCMoxi Chen
Moxi Chen
TXTao Xu
Tao Xu
Background: Opioids remain a primary treatment for moderate‐to‐severe chronic pain, but prolonged use frequently induces analgesic tolerance. Excitatory glutamate receptors, ubiquitous in the central and peripheral nervous systems, are pivotal in physiological and pathological processes and are now recognized as significant contributors to opioid tolerance development.Methods: We comprehensively analyzed experimental data from our team's intensive investigations over the past 10 years, alongside relevant peer‐reviewed studies on glutamate receptor mechanisms in opioid tolerance.Results: Excitatory glutamate receptors (including NMDA, AMPA, and metabotropic subtypes) fundamentally regulate neuroadaptations underlying morphine tolerance. Our work and others' demonstrate their involvement in synaptic plasticity, neuroinflammation, and downstream signaling pathways that drive tolerance.Conclusions: Targeting excitatory glutamate receptors presents a promising therapeutic strategy for mitigating opioid tolerance. Future research should prioritize elucidating receptor‐specific mechanisms, peripheral‐central nervous system crosstalk, and translating preclinical findings into clinically viable.

26 May 2025 in Journal of Integrative Neuroscience
Verified
Journal Article
Open access
ZCZhusheng Chen
Zhusheng Chen
TCTong Cheng
Tong Cheng
HYHaorui Yang
Haorui Yang
YGYongtao Gao
Yongtao Gao
XMXiaqing Ma
Xiaqing Ma
Over the past years, a number of clinical and preclinical investigations have been documented, suggesting treatment strategies and pharmaceuticals for neuropathic pain and depressive disorders, potentially beneficial in cases where these conditions are comorbid. This review lists these potential treatment options and discusses the proposed underlying mechanisms of action and their limitations, in terms of both physiotherapy and pharmacotherapy. Physiotherapy includes electroacupuncture and repetitive transcranial magnetic stimulation therapy, both of which affect neuronal function by altering the physiological state of the neurons. Pharmacological treatments include tricyclic antidepressants, gabapentin, ketamine, minocycline, and Chinese medicine, which alter ion channel activity, affect neurotransmitter release, and exert anti-inflammatory effects. As such, this review may help to improve future research endeavors and therapeutic options for this frequently occurring comorbidity.